Showing results 6 to 6 of 6
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
The PAR-1 antagonist Vorapaxar ameliorates kidney injury and tubulointerstitial fibrosis Journal:Clinical Science | 2020 |
Title | Author(s) | Issue Date | |
---|---|---|---|
The PAR-1 antagonist Vorapaxar ameliorates kidney injury and tubulointerstitial fibrosis Journal:Clinical Science | 2020 |